InfuSystem (NYSE:INFU) Trading Down 1.8% – What’s Next?

Posted by Stanley Muller on Aug 13th, 2026

InfuSystem Holdings, Inc. (NYSE:INFU – Get Free Report) fell 1.8% during trading on Wednesday . The stock traded as low as $12.03 and last traded at $12.24. Approximately 116,417 shares were traded during mid-day trading, a decline of 32% from the average daily volume of 172,024 shares. The stock had previously closed at $12.46.

Analyst Ratings Changes

Separately, B. Riley Financial reiterated a “buy” rating and set a $20.00 price objective (up from $12.00) on shares of InfuSystem in a research note on Wednesday, August 5th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, InfuSystem presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.67.

Get Our Latest Stock Analysis on InfuSystem

InfuSystem Price Performance

The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The company has a market cap of $247.03 million, a P/E ratio of 204.03 and a beta of 1.42. The firm’s fifty day moving average is $9.73 and its two-hundred day moving average is $9.34.

InfuSystem declared that its Board of Directors has approved a stock buyback plan on Tuesday, May 19th that allows the company to repurchase $20.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 10.2% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its shares are undervalued.

Institutional Trading of InfuSystem

Several institutional investors have recently made changes to their positions in the business. North Star Investment Management Corp. lifted its stake in InfuSystem by 527.6% in the 1st quarter. North Star Investment Management Corp. now owns 182,000 shares of the company’s stock worth $1,680,000 after purchasing an additional 153,000 shares in the last quarter. Minerva Advisors LLC boosted its holdings in shares of InfuSystem by 5.2% during the 4th quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company’s stock valued at $9,676,000 after purchasing an additional 52,942 shares during the last quarter. 683 Capital Management LLC purchased a new position in shares of InfuSystem during the fourth quarter valued at about $901,000. Ritholtz Wealth Management grew its position in shares of InfuSystem by 104.9% during the first quarter. Ritholtz Wealth Management now owns 35,870 shares of the company’s stock valued at $331,000 after purchasing an additional 18,362 shares in the last quarter. Finally, Aristides Capital LLC bought a new stake in shares of InfuSystem in the fourth quarter worth about $110,000. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Company Profile

(Get Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.